Healthcare >> CEO Interviews >> January 26, 2004
DR. Martin Barkin is the President and Chief Executive Officer of DRAXIS
Health Inc., and also serves on the Boards of Viventia Biotech Inc. and
Bone Care International, Inc. Dr. Barkin came to DRAXIS in 1992 from
KPMG where he served as Partner and National Practice Leader for Health
Care. Before that, he was Deputy Minister of Health for the Province of
Ontario, Secretary of the Premier's Council on Health and Chair of the
Deputies' Cabinet Committee on Social Policy for the Province of
Ontario. He holds the rank of Professor in the Faculty of Medicine at
the University of Toronto in both the Departments of Surgery and Health
Administration. Dr. Barkin was President and Chief Executive Officer of
Sunnybrook Health Sciences Centre, a 1,400 bed teaching and research
center, at which time he was also Vice Chair of the Ontario Hospital
Association and President of the Ontario Council of Teaching Hospitals.
He was Chief of the Division of Urology, Sunnybrook Health Sciences
Centre, Professor of Surgery (Urology) University of Toronto and a
Project Director at the Research Institute of the Hospital for Sick
Children as well as a member of the Grants Review Committee of the
Medical Research Council of Canada. Profile
with the company recently.
Dr. Barkin: DRAXIS is a specialty pharmaceutical company focused in two
dynamic areas:
